ASSETS HELD-FOR-SALE

12 Months Ended

Dec. 31, 2014

Assets Held-For-Sale [Abstract]

Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]

ASSETS HELD-FOR-SALE

As discussed in "—Note 3. Alliances", BMS sold its diabetes business to AstraZeneca in February 2014 which previously comprised the global alliance with them. The diabetes business was treated as a single disposal group held-for-sale as of December 31, 2013. No write-down was required as the fair value of the business less costs to sell exceeded the related carrying value. Assets held-for-sale at December 31, 2014 are related to alliances with The Medicines Company and Valeant. The allocation of goodwill was based on the relative fair value of the businesses divested to the Company's reporting unit.

The following table provides the assets and liabilities classified as held-for-sale:

Dollars in Millions	December 31, 2014		December 31, 2013
Assets
Receivables	$	—	$	83
Inventories	38		163
Deferred income taxes - current	—		125
Prepaid expenses and other	—		20
Property, plant and equipment	—		678
Goodwill	19		550
Other intangible assets	52		5,682
Other assets	—		119
Assets held-for-sale	$	109	$	7,420
Liabilities
Short-term borrowings and current portion of long-term debt	$	—	$	27
Accounts payable	—		30
Accrued expenses	—		148
Deferred income - current	—		352
Accrued rebates and returns	—		81
Deferred income - noncurrent	—		3,319
Deferred income taxes - noncurrent	—		946
Other liabilities	—		28
Liabilities related to assets held-for-sale	$	—	$	4,931